Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oligo-mannurarate in Mild to Moderate Alzheimer's Disease
NCT01453569Phase 2Completed
- Sponsor
- Green Valley
- Start
- Oct 2011
- Primary completion
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium oligomannate in Alzheimer's disease (AD), sponsored by Green Valley. Started Oct 2011; status: completed.
02
Drugs
sodium oligomannate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT01453569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01453569.